ClinicalTrials.Veeva

Menu

Cancer Survival in Reunion Island , 1998-2008 (SUCRE)

C

Centre Hospitalier Universitaire de la Réunion

Status

Completed

Conditions

Neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT02900287
2014/CHU/05

Details and patient eligibility

About

Cancer survival is important to determine prognostic of patients and evaluate care and prevention health strategies. Sucre is the first study to describe cancer survival in Reunion Island. Sucre aims at evaluating five year cancer prognostic in Reunion Island by cancer site and gender. Sucre is a retrospective cohort study of cancer diagnosed between 01/01/1998 and 31/12/2008.

Full description

Data are extracted from Reunion Island Cancer Registry.

Enrollment

18,000 patients

Sex

All

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients domiciled in Reunion Island at diagnosis
  • Patients with at least 15 years of age at diagnosis
  • Patients with cancer diagnosis between 01/01/1998 and 31/12/2008

Exclusion criteria

  • Cutaneous malignant cancer expected melanoma

Trial contacts and locations

1

Loading...

Central trial contact

Emmanuel CHIRPAZ

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems